Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2434721 | 0.85 | — | — | |
| SCHEMBL1954545 | 0.81 | MAPT (0.30) | CYP4F2CYP4A11MAPTHTTLMNA | |
| SCHEMBL2432046 | 0.80 | — | — | |
| SCHEMBL2426048 | 0.79 | CA1 (0.30) | — | |
| SCHEMBL2427566 | 0.79 | — | — | |
| SCHEMBL2184704 | 0.79 | CYP4F2 (0.38) | CYP4F2CYP4A11MAPTHTTPKM | |
| SCHEMBL2426053 | 0.77 | — | — | |
| SCHEMBL12287366 | 0.77 | — | — | |
| SCHEMBL2431485 | 0.77 | CNR1 (0.30) | — | |
| SCHEMBL2429626 | 0.75 | EPHX1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017656-B2 | Organic sulfur compounds and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-13 | — | — | US | disclosed |
| US-8017656-B2 | Organic sulfur compounds and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20090186941-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090186941-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-23 | — | — | US | disclosed |
| EP-1951664-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF AS ARTHROPODICIDES | Sumitomo Chemical Company, Limited (JP) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007060839-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF AS ARTHROPODICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186941-A1 | ORGANIC SULFUR COMPOUNDS AND USE THEREOF | TST, SQOR, TRPA1 | CYP4F2 627/4885CYP4A11 954/4885MAPT 2254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.